147 related articles for article (PubMed ID: 9316050)
1. The prognostic significance of Ki-67 labeling indices for oligodendrogliomas.
Coons SW; Johnson PC; Pearl DK
Neurosurgery; 1997 Oct; 41(4):878-84; discussion 884-5. PubMed ID: 9316050
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of flow cytometry deoxyribonucleic acid analysis of human oligodendrogliomas.
Coons SW; Johnson PC; Pearl DK; Olafsen AG
Neurosurgery; 1994 Apr; 34(4):680-7; discussion 687. PubMed ID: 8008167
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of cell proliferation, epidermal growth factor receptor, and bcl-2 immunoexpression as prognostic factors for patients with World Health Organization grade 2 oligodendroglioma.
Reis-Filho JS; Faoro LN; Carrilho C; Bleggi-Torres LF; Schmitt FC
Cancer; 2000 Feb; 88(4):862-9. PubMed ID: 10679656
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of the proliferation-related antigen Ki-67 in oligodendrogliomas.
Kros JM; Hop WC; Godschalk JJ; Krishnadath KK
Cancer; 1996 Sep; 78(5):1107-13. PubMed ID: 8780550
[TBL] [Abstract][Full Text] [Related]
5. Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value.
Heesters MA; Koudstaal J; Go KG; Molenaar WM
J Neurooncol; 1999; 44(3):255-66. PubMed ID: 10720205
[TBL] [Abstract][Full Text] [Related]
6. Expression of cyclin A and topoisomerase IIalpha of oligodendrogliomas is correlated with tumour grade, MIB-1 labelling index and survival.
Park SH; Suh YL
Histopathology; 2003 Apr; 42(4):395-402. PubMed ID: 12653952
[TBL] [Abstract][Full Text] [Related]
7. The expression of cell cycle regulatory proteins in oligodendroglial tumors.
Kamiya M; Nakazato Y
Clin Neuropathol; 2002; 21(2):52-65. PubMed ID: 12005253
[TBL] [Abstract][Full Text] [Related]
8. Replicative Mcm2 protein as a novel proliferation marker in oligodendrogliomas and its relationship to Ki67 labelling index, histological grade and prognosis.
Wharton SB; Chan KK; Anderson JR; Stoeber K; Williams GH
Neuropathol Appl Neurobiol; 2001 Aug; 27(4):305-13. PubMed ID: 11532161
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical markers for prognosis of oligodendroglial neoplasms.
Korshunov A; Golanov A; Sycheva R
J Neurooncol; 2002 Jul; 58(3):237-53. PubMed ID: 12187958
[TBL] [Abstract][Full Text] [Related]
10. Value of MIB-1 labelling index (LI) in gliomas and its correlation with other prognostic factors. A clinicopathologic study.
Rodríguez-Pereira C; Suárez-Peñaranda JM; Vázquez-Salvado M; Sobrido MJ; Abraldes M; Barros F; Forteza J
J Neurosurg Sci; 2000 Dec; 44(4):203-9; discussion 209-10. PubMed ID: 11327289
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in oligodendroglioma.
Schiffer D; Dutto A; Cavalla P; Bosone I; Chiò A; Villani R; Bellotti C
Can J Neurol Sci; 1997 Nov; 24(4):313-9. PubMed ID: 9398978
[TBL] [Abstract][Full Text] [Related]
12. Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort.
Pollack IF; Hamilton RL; Burnham J; Holmes EJ; Finkelstein SD; Sposto R; Yates AJ; Boyett JM; Finlay JL
Neurosurgery; 2002 Jun; 50(6):1238-44; discussion 1244-5. PubMed ID: 12015841
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 in oligodendroglial neoplasms.
Castilla EA; Prayson RA; Kanner AA; Rybicki LA; Tubbs RR; Vogelbaum MA; Barnett GH
Cancer; 2003 Oct; 98(7):1465-72. PubMed ID: 14508834
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of DNA topoisomerase II-alpha (Ki-S1), p21/Cip-1, and p27/Kip-1 protein immunoexpression in oligodendrogliomas.
Korshunov A; Golanov A
Arch Pathol Lab Med; 2001 Jul; 125(7):892-8. PubMed ID: 11419973
[TBL] [Abstract][Full Text] [Related]
15. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.
Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW
Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366
[TBL] [Abstract][Full Text] [Related]
16. Role of apoptosis in the prognosis of oligodendrogliomas.
Schiffer D; Dutto A; Cavalla P; Chiò A; Migheli A; Piva R
Neurochem Int; 1997 Aug; 31(2):245-50. PubMed ID: 9220457
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin receptor 2A in gliomas: Association with oligodendrogliomas and favourable outcome.
Kiviniemi A; Gardberg M; Kivinen K; Posti JP; Vuorinen V; Sipilä J; Rahi M; Sankinen M; Minn H
Oncotarget; 2017 Jul; 8(30):49123-49132. PubMed ID: 28467778
[TBL] [Abstract][Full Text] [Related]
18. MIB-1 proliferation index predicts survival among patients with grade II astrocytoma.
McKeever PE; Strawderman MS; Yamini B; Mikhail AA; Blaivas M
J Neuropathol Exp Neurol; 1998 Oct; 57(10):931-6. PubMed ID: 9786243
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas.
Wakimoto H; Aoyagi M; Nakayama T; Nagashima G; Yamamoto S; Tamaki M; Hirakawa K
Cancer; 1996 Jan; 77(2):373-80. PubMed ID: 8625247
[TBL] [Abstract][Full Text] [Related]
20. Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas.
Duregon E; Bertero L; Pittaro A; Soffietti R; Rudà R; Trevisan M; Papotti M; Ventura L; Senetta R; Cassoni P
Oncotarget; 2016 Apr; 7(16):21190-8. PubMed ID: 27049832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
